No idea, but I would assume definitely not in this current market environment. CHM and RAD IPOed during the Bio-Boom and got dragged down like most non-income producing bio-techs. But maybe he takes on ALA which is run by M.Baker, a director of RAD, and IMU is advancing ALA's iNKT platform which he brought to SUD / ALA.
He got enough to do to turn the 3/4 comps around, hardly to think he starts up another one at this stage. Plus the 3/4 comps tackle solid cancers, with a virus, CAR-T applications and radiation. Plenty of opportunities with the 3/4 ones.
Sadly the morning run got turned down due to China and US FED-jitters.
GLTA
No idea, but I would assume definitely not in this current...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |